TY - JOUR
AU1 - Patil, Seema
AU2 - Cross, Raymond
AB - Digestive Diseases and Sciences (2018) 63:2497–2499 https://doi.org/10.1007/s10620-018-5136-y EDITORIAL 1 1 Seema A. Patil  · Raymond K. Cross Published online: 4 June 2018 © Springer Science+Business Media, LLC, part of Springer Nature 2018 Optimal care of patients with inflammatory bowel disease Melanoma rates are increasing annually, with the Amer- (IBD), though usually discussed in terms of diagnostic test- ican Cancer Society estimating there will be 91,270 new ing, procedures, and therapeutic interventions, also requires cases and 9,320 deaths attributed to melanoma in 2018. close attention to preventive care and health maintenance. NMSC is the most common of all types of cancer, with Healthcare maintenance is essential since the medications an estimated 3.3 million Americans diagnosed each year. used for treatment of IBD are accompanied by often prevent- Eighty and twenty percent are basal cell and squamous cell able adverse effects, and also because many IBD patients cancers, respectively. Nevertheless, death from these can- consider their gastroenterologist to be their primary care cers is not common. About 2000 people die from NMSC provider. in the USA each year [4]. No randomized controlled stud- Among all types of cancers, skin cancers appear to among ies have been conducted to establish the efficacy of skin the most increased 
TI - More Skin in the Game: Screening for Skin Cancer in IBD Patients
JF - Digestive Diseases and Sciences
DO - 10.1007/s10620-018-5136-y
DA - 2018-06-04
UR - https://www.deepdyve.com/lp/springer-journals/more-skin-in-the-game-screening-for-skin-cancer-in-ibd-patients-M4jwfV11OE
SP - 2497
EP - 2499
VL - 63
IS - 10
DP - DeepDyve
ER -